These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17522366)

  • 1. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
    Zhang PL; Malek SK; Blasick TM; Pennington JR; Masker KK; Lun M; Potdar S
    Ann Clin Lab Sci; 2007; 37(2):121-6. PubMed ID: 17522366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
    Gallon L; Gagliardini E; Benigni A; Kaufman D; Waheed A; Noris M; Remuzzi G
    Clin J Am Soc Nephrol; 2006 May; 1(3):539-45. PubMed ID: 17699257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.
    Zhang PL; Malek SK; Prichard JW; Lin F; Yahya TM; Schwartzman MS; Latsha RP; Skaletsky M; Norfolk ER; Brown RE; Hartle JE; Potdar S
    Ann Clin Lab Sci; 2004; 34(2):209-13. PubMed ID: 15228236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d-positive renal allograft rejection biopsies in cyclosporine-treated patients: single-center incidence and outcome.
    Valente M; Furian L; Marchini F; Marino S; Cardillo M; Rigotti P; Aiello FB
    Transplant Proc; 2010; 42(6):2214-7. PubMed ID: 20692447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological markers of humoral rejection in renal transplant patients.
    Valente M; Furian L; Marino S; Rigotti P; De Fazio N; Cardillo M; Cusinato R; Aiello FB
    Transplant Proc; 2007; 39(6):1827-9. PubMed ID: 17692623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without Campath-1H (alemtuzumab) induction therapy.
    Zhang PL; Malek SK; Prichard JW; Lin F; Yahya TM; Schwartzman MS; Latsha RP; Norfolk ER; Blasick TM; Lun M; Brown RE; Hartle JE; Potdar S
    Am J Transplant; 2005 Mar; 5(3):604-7. PubMed ID: 15707416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fate of C4d positive kidney allografts lacking histological signs of acute rejection.
    Dickenmann M; Steiger J; Descoeudres B; Mihatsch M; Nickeleit V
    Clin Nephrol; 2006 Mar; 65(3):173-9. PubMed ID: 16550748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal peritubular capillary C4d deposition in acute rejection.
    Magil AB; Tinckam KJ
    Nephrol Dial Transplant; 2006 May; 21(5):1382-8. PubMed ID: 16396975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
    Trzonkowski P; Zilvetti M; Friend P; Wood KJ
    Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome.
    Nair R; Fraer M; Agrawal N; Suneja M
    Transplant Proc; 2010 Nov; 42(9):3507-12. PubMed ID: 21094805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campath-1H use in pediatric renal transplantation.
    Bartosh SM; Knechtle SJ; Sollinger HW
    Am J Transplant; 2005 Jun; 5(6):1569-73. PubMed ID: 15888071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
    Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
    Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of C4d staining with minimal histologic abnormalities.
    Haas M
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
    Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
    Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
    Garcia M; Weppler D; Mittal N; Nishida S; Kato T; Tzakis A; Ruiz P
    Transplant Proc; 2004 Mar; 36(2):323-4. PubMed ID: 15050146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.